Filing Details

Accession Number:
0001209191-21-037697
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-03 16:42:50
Reporting Period:
2021-06-01
Accepted Time:
2021-06-03 16:42:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1845337 Day One Biopharmaceuticals Inc. DAWN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1326628 Len Blavatnik C/O Access Industries, Inc.
40 West 57Th Street, 28Th Fl
New York NY 10019
No No No Yes
1391297 Access Industries Holdings Llc C/O Access Industries, Inc.
40 West 57Th Street, 28Th Fl
New York NY 10019
No No No Yes
1508226 Access Industries Management, Llc C/O Access Industries, Inc.
40 West 57Th Street, 28Th Floor
New York NY 10019
No No No Yes
1863302 Ai Day 1 Llc C/O Access Industries, Inc.
40 West 57Th Street, 28Th Floor
New York NY 10019
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-01 8,502,776 $0.00 8,502,776 No 4 C Direct
Common Stock Acquisiton 2021-06-01 875,000 $16.00 9,377,776 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Redeemable Convertible Preferred Stock Disposition 2021-06-01 7,761,380 $0.00 7,761,380 $0.00
Common Stock Series B Redeemable Convertible Preferred Stock Disposition 2021-06-01 741,396 $0.00 741,396 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Each share of Series A Redeemable Convertible Preferred Stock automatically converted into one share of common stock of Day One Biopharmaceuticals, Inc. (the "Issuer") immediately prior to the completion of the Issuer's initial public offering and had no expiration date.
  2. Each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of common stock of the Issuer immediately prior to the completion of the Issuer's initial public offering and had no expiration date.
  3. The securities reported are held directly by AI Day 1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day 1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.
  4. Represents securities purchased in the Issuer's initial public offering.